The estimated Net Worth of Terence M Berge is at least $8.08 Million dollars as of 28 April 2023. Terence Berge owns over 18,700 units of Conmed stock worth over $1,444,500 and over the last 10 years Terence sold CNMD stock worth over $6,640,371.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Sign up
Terence Berge CNMD stock SEC Form 4 insiders trading
Terence has made over 28 trades of the Conmed stock since 2015, according to the Form 4 filled with the SEC. Most recently Terence exercised 18,700 units of CNMD stock worth $1,364,726 on 28 April 2023.
The largest trade Terence's ever made was exercising 30,900 units of Conmed stock on 6 August 2019 worth over $1,359,909. On average, Terence trades about 5,989 units every 90 days since 2015. As of 28 April 2023 Terence still owns at least 19,704 units of Conmed stock.
You can see the complete history of Terence Berge stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Terence Berge's mailing address?
Terence's mailing address filed with the SEC is C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO, FL, 33773.
Insiders trading at Conmed
Over the last 5 years, insiders at Conmed have traded over $0 worth of Conmed stock. The most active insiders traders include Curt R Hartman, Daniel S Jonas, and Terence M Berge. On average, Conmed executives and independent directors trade stock every 0 days with the average trade being worth of $58,501. The most recent stock trade was executed by John Jed Kennedy on 28 February 2020, trading 1,575 units of CNMD stock currently worth $115,463.
What does Conmed do?
conmed corporation is a global medical technology company that specializes in the development and sale of surgical and patient monitoring products and services that allow our physician customers to deliver high quality care and as a result, enhanced clinical outcomes for their patients. our products are technological leaders in the specialties that we serve: orthopaedics, general surgery, gynecology, gastroenterology, pulmonology, and anesthesiology. conmed's mission, and the focus of every employee around the world, is to improve the quality of health care by designing, producing and marketing innovative, high-quality products. our emphasis is on our customer’s satisfaction and on our enhanced patient outcomes. we strive to demonstrate thoughtful leadership, provide meaningful opportunities for employees, and be a responsible member of the local communities in which we conduct business. conmed is headquartered in beautiful, upstate new york (utica), and employs approximately 3500
What does Conmed's logo look like?
Complete history of Terence Berge stock trades at Conmed and Conmed
Conmed executives and stock owners
Conmed executives and other stock owners filed with the SEC include:
-
Curt R. Hartman,
Chairman, CEO & Pres -
Patrick J. Beyer,
Pres of International & Global Orthopedics -
Todd W. Garner,
Exec. VP & CFO -
Daniel S. Jonas Esq.,
Exec. VP of Legal Affairs, Gen. Counsel & Sec. -
Stanley W. Peters III,
VP & GM of U.S. Advanced Surgical -
John E. Kennedy,
Group Exec. VP of Advanced Endoscopic Technologies, QA/RA, Distribution & Customer Service -
David R. Murray,
Pres of ConMed Electrosurgery -
Shanna L. Cotti-Osmanski,
Exec. VP of Information Technology & CIO -
Heather L. Cohen,
Exec. VP of HR -
Peter K. Shagory,
Exec. VP of Strategy & Corp. Devel. -
Daniel S. Jonas,
Exec. VP of Legal Affairs, Gen. Counsel & Sec. -
Terence M Berge,
VP-Corporate Controller -
Pat Beyer,
President - International -
Heather L Cohen,
EVP CORP HR -
Nathan Folkert,
VP GM Orthopedics -
Todd W Garner,
Executive Vice President & CFO -
Daniel S Jonas,
EVP Legal Affairs,Gen. Counsel -
Johonna Marie Pelletier,
Treasurer and VP, Tax -
Wilfredo Ruiz Caban,
EVP QA, RA and Operations -
Curt R Hartman,
President & CEO -
Stanley W Iii Peters,
VP GM Advanced Surgery -
Peter K Shagory,
EVP, STRAT & CORP DEVT -
John Jed Kennedy,
VP GM CET